Yatırımcı.AI

ECILC vs RTALB Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and RTALB side by side.

ECILCRTALB
StockFund

If you had invested TRY 10,000

Metric comparison

ECILC vs RTALB Comparison
MetricECILCRTALBSector median
Last price (TL)63.901.9918.72
Daily change−6.72%−1.00%−4.81%
Market capTRY 43.8BTRY 995MTRY 4.4B
P/E—20.6218.20
P/B0.680.341.14
Dividend yield2.04%—0.90%
Return on equity−3.08%1.85%1.78%
Free float22.02%84.53%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the ECILC vs RTALB comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and RTALB (Rta Laboratuvarlari) side by side as of Sep 28, 2026, 12:16. Of the 15 metrics compared, ECILC leads in 4 and RTALB leads in 11.

Highlights: Daily change: RTALB leads (−1.00% vs −6.72%). Market cap: ECILC leads (TRY 43.8B vs TRY 995M). P/B: RTALB leads (0.34 vs 0.68). EV/EBITDA: ECILC leads (165.19 vs −218.25). EV/Sales: RTALB leads (5.49 vs 9.35). Gross margin: ECILC leads (37.83% vs 22.17%). EBITDA margin (annual): ECILC leads (11.49% vs 2.49%). Net margin (annual): RTALB leads (17.87% vs −20.86%).

Frequently asked questions

By P/E, Tie is cheaper (— vs 20.62); by P/B, RTALB trades at the lower multiple (0.68 vs 0.34).

Annual net margin is −20.86% for ECILC and 17.87% for RTALB; return on equity is −3.08% for ECILC and 1.85% for RTALB.

The leverage ratio is 18.92 for ECILC and 11.00 for RTALB; net debt/EBITDA is 1.37 for ECILC and −8.71 for RTALB. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.